Literature DB >> 15472588

Causes of varicose vein recurrence: late results of a randomized controlled trial of stripping the long saphenous vein.

Rebecca J Winterborn1, Chris Foy, Jonothan J Earnshaw.   

Abstract

BACKGROUND: The purpose of this study was to investigate the long-term outcomes following stripping of the long saphenous vein during primary varicose vein surgery and to identify factors which may predict recurrence and the need for reoperation.
METHODS: The original study was designed as a randomized trial of 100 patients (133 legs) who underwent saphenofemoral ligation with or without long saphenous vein stripping. After invitation 11 years later, 51 patients (74 legs) underwent clinical review and duplex imaging and completed an Aberdeen Varicose Vein Symptom Severity Score (AVVSSS). The hospital notes of the original cohort of patients were used to compile cumulative data and assess predictive factors.
RESULTS: A cumulative total of 83 legs had developed clinically recurrent varicose veins by 11 years (62%). There was no statistically significant difference between the ligation-only and the stripping groups. Reoperation was required for 20 of 69 legs that underwent ligation alone compared with 7 of 64 legs that had additional long saphenous vein stripping (relative risk [RR], 2.65; 95% confidence interval, 1.20 to 5.84; P = .012). By life table analysis, freedom from reoperation at 11 years was 70% after ligation, compared with 86% after stripping ( P = .01). The presence of neovascularization (RR, 2.88; P = .15) , an incompetent superficial vessel in the thigh (RR, 3.24; P = .03) or an incompetent saphenofemoral junction on duplex imaging at 2 years postoperatively (RR, 4.89; P = .0001) increased the risk of a patient's developing clinically recurrent veins. Patients with visible recurrent varicose veins had a significantly worse AVVSSS ( P = .001).
CONCLUSION: Stripping the long saphenous vein is recommended as part of routine varicose vein surgery as it reduced the risk of reoperation by 60% after 11 years, although it did not reduce the rate of visible recurrent veins.

Entities:  

Mesh:

Year:  2004        PMID: 15472588     DOI: 10.1016/j.jvs.2004.07.003

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  18 in total

Review 1.  Significance of Reflux Abolition at the Saphenofemoral Junction in Connection with Stripping and Ablative Methods.

Authors:  Cestmir Recek
Journal:  Int J Angiol       Date:  2015-03-23

Review 2.  The treatment of varicose veins.

Authors:  S Subramonia; T A Lees
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

Review 3.  Varicose veins.

Authors:  Paul Tisi
Journal:  BMJ Clin Evid       Date:  2007-10-18

4.  The hemodynamic paradox as a phenomenon triggering recurrent reflux in varicose vein disease.

Authors:  Cestmir Recek
Journal:  Int J Angiol       Date:  2012-09

Review 5.  Varicose veins.

Authors:  Paul V Tisi
Journal:  BMJ Clin Evid       Date:  2011-01-05

6.  Varicose vein surgery.

Authors:  Michael Ombrellino; Lowell S Kabnick
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

7.  Neovascularisation is not an innocent bystander in recurrence after great saphenous vein surgery.

Authors:  C R R Corbett; V Prakash
Journal:  Ann R Coll Surg Engl       Date:  2015-03       Impact factor: 1.891

Review 8.  CHIVA method for the treatment of chronic venous insufficiency.

Authors:  Sergi Bellmunt-Montoya; Jose Maria Escribano; Jaume Dilme; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

9.  Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial.

Authors:  Manjit S Gohel; Jamie R Barwell; Maxine Taylor; Terry Chant; Chris Foy; Jonothan J Earnshaw; Brian P Heather; David C Mitchell; Mark R Whyman; Keith R Poskitt
Journal:  BMJ       Date:  2007-06-01

10.  Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system.

Authors:  Alexander Kuhlmann; Anne Prenzler; Jan Hacker; J-Matthias Graf von der Schulenburg
Journal:  Health Econ Rev       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.